21 Feb 2019 --- Lallemand Health Solutions (LHS) and product development company ComboCap Inc. have entered into a partnership and signed a license agreement for the co-development of a new global probiotics product category that involves dual-chamber, wet-and-dry oral probiotics previously unavailable due to ingredient incompatibility. This new solution seeks to allow a broader nutritional offering to consumers, which promises significant potential for enhanced long term results, improved compliance and the creation of unique products, Lallemand says.
